Back to results
US 2022/0175726 A1Published application
Stable preservative-free mydriatic and anti-inflammatory solutions for injection
AssigneeOmeros Corporation
InventorsGregory A. Demopulos, Hui-rong Shen, Clark E. Tedford
Life of this patent
Estimating the term…
Abstract
The present invention relates to stable, preservative- and antioxidant-free liquid formulations of phenylephrine and ketorolac for injection.
Claims9
A liquid pharmaceutical dosage form comprising phenylephrine, ketorolac, a buffer system, an intraocular irrigation carrier and an inter-gas overlay in a single-use container, wherein the phenylephrine is included at a concentration of from 30 to 720 μM and the ketorolac is included at a concentration of from 10 to 270 μM.
Dependencies are inferred from the claim text.